Preventative drugs are a key area of research for Prevent Breast Cancer. We recognise that there may be drugs currently used in the treatment of breast cancer that could be of benefit to those at increased risk.
Thanks to researchers at Prevent Breast Cancer, there have been some recent changes to NICE guidelines (July 2013), which mean that tamoxifen and raloxifene (drugs also used for treating breast cancer) are now recommended for women at increased risk of breast cancer in order to reduce their risk.
Projects that are and have recently been funded by Prevent Breast Cancer include:
- Anti-Prolactin for Prevention – There is an urgent need for effect, well-tolerated and safe breast cancer preventative drugs
- DCIS and Clotting – Looking at how anti-coagulants could stop the spread of early cancer.